Intact interferon signaling in peripheral blood leukocytes of high-grade osteosarcoma patients

High-grade osteosarcoma has a poor prognosis with an overall survival rate of about 60 percent. The recently closed European and American Osteosarcoma Study Group (EURAMOS)-1 trial investigates the efficacy of adjuvant chemotherapy with or without interferon-α. It is however unknown whether the inte...

詳細記述

保存先:
書誌詳細
主要な著者: Buddingh, Emilie P., Ruslan, S. Eriaty N., Berghuis, Dagmar, Gelderblom, Hans, Anninga, Jakob K., Hogendoorn, Pancras C. W., Egeler, R. Maarten, Schilham, Marco W., Lankester, Arjan C.
フォーマット: Artigo
言語:Inglês
出版事項: Springer-Verlag 2012
主題:
Short Communication
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC3362707/
https://ncbi.nlm.nih.gov/pubmed/22402907
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00262-012-1232-6
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料